HomeNewsIndia80% kids in 14-18 yrs in India reported low levels of learning during Covid pandemic: UNICEF report

80% kids in 14-18 yrs in India reported low levels of learning during Covid pandemic: UNICEF report

Noting that repeated school closures have led to alarming inequities in learning opportunities for children in South Asia, the report pointed out that 76 per cent of parents of students aged 5-13 years reported drop in learning levels during remote learning.

September 09, 2021 / 22:38 IST
Story continues below Advertisement
Representative Image
Representative Image

At least 80 per cent children in India between the age group of 14-18 years reported lower levels of learning during COVID-19 pandemic than when physically at school, according to a UNICEF report.

Noting that repeated school closures have led to alarming inequities in learning opportunities for children in South Asia, the report by the United Nations International Children''s Emergency Fund (UNICEF) pointed out that 76 per cent of parents of students aged 5-13 years reported drop in learning levels during remote learning.

Story continues below Advertisement

"School closures in South Asia have forced hundreds of millions of children and their teachers to transition to remote learning in a region with low connectivity and device affordability. Even when a family has access to technology, children are not always able to access it. As a result, children have suffered enormous setbacks in their learning journey," George Laryea-Adjei, UNICEF Regional Director for South Asia, said.

In India, 42 per cent of children between 6-13 years reported not using any type of remote learning during school closures.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show